Assessment of the prevalence of the 985A>G MCAD mutation in the French-Canadian population using allele-specific PCR

被引:14
作者
Giroux, S.
Dube-Linteau, A.
Cardinal, G.
Labelle, Y.
Laflamme, N.
Giguere, Y.
Rousseau, F.
机构
[1] Hosp Univ Quebec, Ctr Rech, Unite Rech & Genet Humaine & Mol, Quebec City, PQ G1L 3L5, Canada
[2] Univ Laval, Fac Med, Dept Biol Med, Laval, PQ, Canada
[3] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada
[4] CanGeneTest Res Consortium, Ctr Dev Evaluat & Rat Implementat New Diagnost To, Genet Lab Serv, Quebec City, PQ, Canada
关键词
DNA pooling; French-Canadian; MCAD; mutation; prevalence; COA DEHYDROGENASE-DEFICIENCY; TANDEM MASS-SPECTROMETRY; CHAIN ACYL-COENZYME; COST-EFFECTIVENESS; DNA POOLS; DIAGNOSIS; GENE; FREQUENCY; IDENTIFICATION; OLIGONUCLEOTIDES;
D O I
10.1111/j.1399-0004.2007.00809.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Inherited deficiency of medium-chain acyl-CoA dehydrogenase (MCAD) is a severe, sometimes fatal disorder. A single mutation in the MCAD gene, 985A>G, is involved in approximately 90% of cases. To evaluate the relevance of implementing a systematic population-based screening program in the province of Quebec using a biochemical test, we measured the prevalence of this mutation in a set of anonymous newborn samples from the Quebec City area, a region where the majority of its inhabitants are French-Canadians. An allele-specific polymerase chain reaction assay was designed and used to detect the mutation in 7143 DNA samples obtained from consecutive anonymous newborns. Pools of eight DNA samples were genotyped in parallel for the same mutation to validate this pooling strategy. The allelic frequency of the MCAD 985A>G mutation was found to be 0.71% and the carrier frequency 1:71 (95% confidence interval 1:55 to 1:98). This estimate predicts a homozygous frequency of 1:19,837. Ninety-nine heterozygous carriers and one homozygous individual were identified out of 7143 samples. There was 100% concordance between the individual and pooled analyses, and the pooling strategy reduced the total genotyping costs by approximately 70%. The carrier frequency estimated for this population is similar to other northwestern European populations and would support implementation of systematic newborn screening (such as tandem mass spectrometry screening) for this disease. Pooling DNA samples followed by genotyping appears to be cost-effective for estimating prevalence of rare mutations.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 48 条
[1]  
Alluri Vinod N, 2002, J Okla State Med Assoc, V95, P326
[2]   Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency [J].
Andresen, BS ;
Dobrowolski, SF ;
O'Reilly, L ;
Muenzer, J ;
McCandless, SE ;
Frazier, DM ;
Udvari, S ;
Bross, P ;
Knudsen, I ;
Banas, R ;
Chace, DH ;
Engel, P ;
Naylor, EW ;
Gregersen, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1408-1418
[3]   ANALYSIS OF ABNORMAL URINARY METABOLITES IN THE NEWBORN PERIOD IN MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY [J].
BENNETT, MJ ;
COATES, PM ;
HALE, DE ;
MILLINGTON, DS ;
POLLITT, RJ ;
RINALDO, P ;
ROE, CR ;
TANAKA, K .
JOURNAL OF INHERITED METABOLIC DISEASE, 1990, 13 (05) :707-715
[4]   PRENATAL-DIAGNOSIS OF MEDIUM-CHAIN ACYL-COENZYME A DEHYDROGENASE-DEFICIENCY [J].
BENNETT, MJ ;
ALLISON, F ;
LOWTHER, GW ;
GRAY, RGF ;
JOHNSTON, DI ;
FITZSIMMONS, JS ;
MANNING, NJ ;
POLLITT, RJ .
PRENATAL DIAGNOSIS, 1987, 7 (02) :135-141
[5]   FREQUENCY OF THE G985 MCAD MUTATION IN THE GENERAL-POPULATION [J].
BLAKEMORE, AIF ;
SINGLETON, H ;
POLLITT, RJ ;
ENGEL, PC ;
KOLVRAA, S ;
GREGERSEN, N ;
CURTIS, D .
LANCET, 1991, 337 (8736) :298-299
[6]   Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation [J].
Blois, B ;
Riddell, C ;
Dooley, K ;
Dyack, S .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (04) :551-556
[7]   Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies [J].
Carpenter, K ;
Wiley, V ;
Sim, KG ;
Heath, D ;
Wilcken, B .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2001, 85 (02) :F105-F109
[8]  
CHARBONNEAU H, 1987, NAISSANCE UNE POPULA
[9]  
Craig I, 2005, METH MOL B, V311, P147
[10]  
CURTIS D, 1991, CLIN GENET, V40, P283